ScreenerHero

VRXA Veraxa Biotech AG

NAS · US · Healthcare · Biotechnology · veraxa.com
1.200USD+11.11%Mkt Cap: 169.69M $P/E: —

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody forma…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap169.69M USD
Enterprise Value—
Revenue (TTM)23.43K USD
Gross Profit15.46K USD
Net Income (TTM)-66.61M USD
Revenue/Share0.0020 USD
Last Price1.200 USD
Fiscal Year EndDec 2025
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S6519.27
P/B-0.84
EPS (TTM)-0.55
EPS (Forward)—
52W Range
1.0401% of range27.36
52W High27.36 USD
52W Low1.040 USD
Profitability
Gross Margin66.00%
Oper. Margin-282662.74%
EBITDA Margin0.00%
Profit Margin-284359.22%
ROE422.51%
ROA-82.42%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.90M USD
CapEx (TTM)437.18K USD
FCF Margin67237.98%
FCF Yield9.28%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.14
Current Ratio0.44
Quick Ratio0.42
Book Value/Sh-1.29 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.141.41M
Float3.84M
Insiders69.92%
Institutions0.86%
Short Interest
Short Ratio0.5d
Short % Out.0.15%
Shares Short209.73K
Short (prev mo.)378.22K
Technical
SMA 501.632 (-26.5%)
SMA 2007.871 (-84.8%)
Beta0.19
S&P 52W Chg15.78%
Avg Vol (30d)317.71K
Avg Vol (10d)77.11K
Technical Indicators
RSI (14)35.4
MACD-0.1655
MACD Signal-0.1641
MACD Hist.-0.0014
BB Upper1.726 USD
BB Middle1.379 USD
BB Lower1.033 USD
BB Width50.18%
ATR (14)0.1348 USD
Vol Ratio (20d)7.07x